Email address
[email protected]Contact number
+44 20 7556 4518Share profile
Band 3
Provided by Simon Amies
Simon is a partner in Cooley’s life sciences practice advising on mergers & acquisitions (public and private), initial public offerings and other capital-raising transactions, and venture and growth capital investments. Simon has extensive experience in advising companies at all stages of their development, as well as counseling investors and investment banks. He has represented a wide range of clients in the life sciences, technology and sustainable technology industries.
Simon’s representative experience includes advising:
* Oxford Biomedica PLC (LSE) on its £60 million placing of ordinary shares
* Medicxi and other investors in the sale of Vicebio to Sanofi for up to $1.6 billion
* EsoBiotec SA on its sale to AstraZeneca for up to $1 billion
* Araris Biotech on its sale to Taiho Pharmaceutical for up to $1.14 billion
* Kheiron Medical Technologies Limited on its sale to DeepHealth
Provided by Chambers
Simon Amies is recommended for his stewardship of high-value, cross-border mergers, acquisitions and financings. His clients include leading innovators in pharma, biotech and health tech.
Provided by Chambers
Simon is very calm, commercial and savvy.
Simon continually displays a deep understanding of our legal needs and business constraints. He is personable, reliable and knowledgeable.
Simon is very calm, commercial and savvy.
Simon continually displays a deep understanding of our legal needs and business constraints. He is personable, reliable and knowledgeable.